Ergoteles’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Ergoteles’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,448	Closed	-$139K	–	2102
2022 Q2	$139K	Buy	+3,448	New	+$213K	﹤0.01%	1440

Other funds holding NEXI

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Allen Operations New York $670M AUM 26.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

KHCM

Kettle Hill Capital Management New York $399M AUM 10.05% 1-Year Est. Return

Ergoteles's NEXI Position: Q3 2022 in Review

Ergoteles sold out of NexImmune, Inc. Common Stock (NEXI) in Q3 2022, closing a stake of 3,448 shares — an estimated $139K sold.

Ergoteles first reported a position in NEXI in Q2 2022 and held it in 1 quarter. The position peaked at $139K in Q2 2022. 38 funds tracked by Wall St. Rank hold NEXI as of Q3 2022.

Ergoteles reported no remaining NexImmune, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Ergoteles sold 3,448 NexImmune, Inc. Common Stock shares in Q3 2022, an estimated $139K.
Ergoteles first reported a position in NexImmune, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Ergoteles's NexImmune, Inc. Common Stock position peaked at $139K in Q2 2022.
38 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q3 2022.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.